AI Research3 weeks ago
AstraZeneca signs AI research deal with China’s CSPC for chronic diseases
(Reuters) -AstraZeneca has signed an AI-led research agreement with China’s CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies...
